Compass Ion Advisors’s Compugen CGEN Stock Holding History
Bought
Maintained
Sold
Other funds holding CGEN
DKCM
TFCM
RSCM
AIM
Compass Ion Advisors's CGEN Position: Q3 2022 in Review
Compass Ion Advisors sold out of Compugen (CGEN) in Q3 2022, closing a stake of 15,000 shares — an estimated $28K sold.
Compass Ion Advisors first reported a position in CGEN in Q4 2021 and held it in 3 quarters. The position peaked at $65K in Q4 2021. 81 funds tracked by Wall St. Rank hold CGEN as of Q3 2022.
- Compass Ion Advisors reported no remaining Compugen position as of Q3 2022 after selling out during the quarter.
- Compass Ion Advisors sold 15,000 Compugen shares in Q3 2022, an estimated $28K.
- Compass Ion Advisors first reported a position in Compugen in Q4 2021 and held it in 3 quarters.
- Compass Ion Advisors's Compugen position peaked at $65K in Q4 2021.
- 81 funds tracked by Wall St. Rank held Compugen as of Q3 2022.
Based on Compass Ion Advisors's 13F filing for Q3 2022, filed 18 Oct 2022.